61 related articles for article (PubMed ID: 16783081)
1. Prognostic Impact of Baseline Immunologic Profile in Aggressive B-cell non-Hodgkin's Lymphomas.
Ramadan S; Ceparano G; Cignetti A; Sammassimo S; Bagnardi V; Pagan E; Gottardi D; Fiori S; Passerini R; Radice T; Saglio G; Tarella C
Mediterr J Hematol Infect Dis; 2021; 13(1):e2021018. PubMed ID: 33747399
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 expression in lymphoma in north-west of iran.
Sanaat Z; Tavangar SM; Gharamaleki JV; Kermani IA; Ziae JE; Nikanfar A; Esfahani A; Chavoshi SH; Bevrani H; Akbari F
Int J Hematol Oncol Stem Cell Res; 2013; 7(1):1-4. PubMed ID: 24505512
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of C-reactive protein and its prognostic relationship in patients with Hodgkin's Lymphoma.
Negreiros E; Bueno da Silveira TM; Fortier SC; Chiattone CS
Hematol Transfus Cell Ther; 2023 Dec; ():. PubMed ID: 38233302
[TBL] [Abstract][Full Text] [Related]
4. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
[TBL] [Abstract][Full Text] [Related]
5. [Primary extralymphatic non-Hodgkin's lymphomas: the response to treatment and prognostic factors in 73 patients].
Oriol A; Ribera JM; Flores A; Batlle M; las Heras G; Vaquero M; Juncá J; Millá F; Feliu E
Med Clin (Barc); 1995 Mar; 104(8):281-6. PubMed ID: 7700086
[TBL] [Abstract][Full Text] [Related]
6. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors in indolent and aggressive lymphomas and its influence on disease outcome.
Zodelava M; Betaneli M; Tsartsidze E; Kharabadze M
Georgian Med News; 2009 Feb; (167):32-6. PubMed ID: 19276466
[TBL] [Abstract][Full Text] [Related]
8. Aggressive non-Hodgkin's lymphoma: T-cell versus B-cell.
Liang R; Todd D; Ho FC
Hematol Oncol; 1996 Mar; 14(1):1-6. PubMed ID: 8613131
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of immunophenotype in aggressive non-Hodgkin's lymphoma.
Tsartsidze E; Betaneli M
Georgian Med News; 2006 May; (134):107-9. PubMed ID: 16783081
[TBL] [Abstract][Full Text] [Related]
10. [Histopathology of malignant lymphomas].
Yamabe H
Rinsho Byori; 1990 Apr; 38(4):386-9. PubMed ID: 2195192
[TBL] [Abstract][Full Text] [Related]
11. [Biology and differentiation of lymphocytes in the classification of lymphomas].
Mariuzzi G; Di Loreto C; Mariuzzi L
Recenti Prog Med; 1990 Oct; 81(10):621-8. PubMed ID: 2291005
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders.
Tbakhi A; Edinger M; Myles J; Pohlman B; Tubbs RR
Cytometry; 1996 Oct; 25(2):113-24. PubMed ID: 8891441
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]